<DOC>
	<DOCNO>NCT00038142</DOCNO>
	<brief_summary>Objectives : 1 . To determine dose intensive Vincristine , Doxorubicin , Cyclophosphamide Dexrazoxane ( VACdxr ) without ImmTherTM improve 2-year disease-free survival see standard VAC therapy . 2 . To evaluate feasibility describe toxicity associate VACdxr . 3 . To evaluate feasibility describe toxicity administer ImmTherTM weekly basis 50- 52 week . 4 . To determine therapy ( VACdxr+ VACdxr- ) worthy evaluation .</brief_summary>
	<brief_title>Vincristine , Doxorubicin , Cyclophosphamide Dexrazoxane ( VACdxr ) High Risk Ewing 's Sarcoma Patients</brief_title>
	<detailed_description>Patients assign random ( toss coin ) receive 1 2 treatment . Arm A : VACdxr give 2 day needle vein . On day 1 , vincristine give 15 minute , doxorubicin give 30 minute . Dexrazoxane give 30 minute doxorubicin ; drug protect heart damage doxorubicin . Cyclophosphamide give day day 1 2 . This make 1 cycle VACdxr treatment ; cycle repeat every 3 week 6 cycle . To prevent side effect VACdxr , drug Mesna Neupogen/or Neulasta also give . Mesna help prevent bladder damage . Neupogen growth factor stimulate body make white blood cell . Neulasta growth factor relate Neupogen . After cycle 3 , surgery may do remove tumor remain . The principal investigator also decide whether radiation treatment do . If , patient receive radiation therapy . Starting 1 month treatment do , patient receive ImmTher . ImmTher stimulate body 's white blood cell attack kill tumor cell . The drug give needle vein 1 hour , every week 1 year . Arm B : Patients treat patient Arm A , except receive ImmTher . Patients may stay hospital VACdxr treatment surgery . Patients receive ImmTher outpatient clinic . Before treatment start , patient complete exam include blood urine test EKG ECHO multiple gate acquisition scan ( MUGA ) ( heart function test ) . X-rays CT , MRI , bone marrow aspiration , bone scan do . Women pregnancy test . After treatment drug , surgery , radiation treatment , patient checkups . These include blood urine test sometimes x-ray . After cycle 3 VACdxr , patient chest x-ray x-ray primary tumor . CT chest , MRI , bone marrow aspiration bone scan do 3 cycle indicate . These test do record measure tumor . After treatment stop , patient return checkup every 3 month 2 year . This investigational study . ImmTher investigational agent . All study drug approve U.S. Food Drug Administration . As many 104 patient take part study ; 95 treat M.D . Anderson .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Dexrazoxane</mesh_term>
	<mesh_term>Razoxane</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Acetylmuramyl-Alanyl-Isoglutamine</mesh_term>
	<criteria>High risk Ewing 's Family tumor ( metastatic disease diagnosis , humerus , femur trunk primary , bulky primary ( great 8 cm ) ) , LDH great equal 900 IU/ml prior biopsy . No prior chemotherapy . Written informed consent Normal cardiac function ( ejection fraction great equal 50 % ) . Males non pregnant female . Biologic age 360 year old . Adequate bone marrow function ( define absolute peripheral granulocyte count &gt; 500/mm3 , platelet count &gt; 75,000/mm3 , hemoglobin &gt; 8g/dl transfusion require ) . Adequate renal function define blood urea nitrogen ( BUN ) &lt; 30mg % serum creatinine &lt; 1.5 x normal age creatinine clearance &gt; 70 . Patients child bear potential must agree use effective method contraception . Normal hepatic function ( bilirubin &lt; 1.5mg/dl , serum glutamate oxaloacetate transaminase ( SGOT ) serum glutamate pyruvate transaminase ( SGPT ) &lt; 3x normal ) . N/A</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Ewing 's Sarcoma</keyword>
	<keyword>Vincristine</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Adriamycin</keyword>
	<keyword>Rubex</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Dexrazoxane</keyword>
	<keyword>Zinecard</keyword>
	<keyword>VACdxr</keyword>
	<keyword>ImmTher</keyword>
</DOC>